Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,909.90 +282.60 1.81%
Hang Seng 22,987.80 -273.31 -1.17%
S&P/ASX 200 5,084.50 -80.87 -1.57%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Source Markets PLC - Health Care S&P US Select Sector Source ETF

+ Add to Watchlist

XLVS:LN

210.4500 USD 4.8000 2.33%

As of 11:35:09 ET on 05/22/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Source Markets PLC - Health Care S&P US Select Sector Source ETF (XLVS)

Open: 209.8000 High - Low: 210.4500 - 209.8000 Primary Exchange: London
Volume: 28,860 52-Week Range: 147.3900 - 210.4500 Beta vs SPSUHCN: 0.9641

ETF Chart for XLVS

No chart data available.
  • XLVS:LN 210.4500
  • 1D
  • 1M
  • 1Y
205.6500
Interactive XLVS Chart

Previous Close

Fund Profile & Information for XLVS

Source Markets plc - Health Care S&P US Select Sector Source ETF is a UCITS III compliant exchange-traded investment fund incorporated in Ireland. The objective of the fund is to track the performance of the S&P Select Sector Capped 20% (Health Care) Net Total Return Index.

Inception Date: 2010-01-05 Telephone: +44-20-3370-1100
Managers: -
Web Site: www.source.info

Fundamentals for XLVS

NAV (on 2013-05-21) 207.2094
Assets (M) (on 2013-05-21) 46.8072
Shares out (M) 0.23
Market Cap (M) 47.54
% Premium -0.75
Average 52-Week % Premium -0.0478
Fund Leveraged N

Dividends for XLVS

No dividends reported

Performance for XLVS

1-Month +3.07% 1-Year +36.56%
3-Month +13.86% 3-Year +20.92%
Year To Date +25.11% 5-Year -
Expense Ratio 0.30

Top Fund Holdings for XLVS

Filing Date: 04/02/2013
Name Position Value % of Total
Johnson & Johnson 29,747 2,437,212 13.047%
Pfizer Inc 76,505 2,206,411 11.811%
Merck & Co Inc 32,164 1,426,461 7.636%
Amgen Inc 7,965 814,870 4.362%
Gilead Sciences Inc 16,201 777,331 4.161%
Bristol-Myers Squibb Co 17,425 716,846 3.837%
AbbVie Inc 16,821 691,692 3.703%
UnitedHealth Group Inc 10,907 643,194 3.443%
Eli Lilly & Co 10,624 601,403 3.219%
Abbott Laboratories 16,715 590,206 3.159%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil